-
2023-508726-10-00
5
2018-03-28
Hepatocellular Carcinoma
-
2024-518741-21-00
4
2014-12-23
colon cancer
-
2024-515996-37-00
3
2021-07-30
peritoneal carcinosis of ovarian origin cancer
-
2024-517751-13-01
4
2024-12-26
Psychiatric disorders
-
2023-509684-24-00
7
2024-10-31
Hepatitis B
-
2024-511998-30-00
5
2024-10-18
Narcolepsy with Cataplexy (Narcolepsy Type 1)
-
2023-506000-50-00
4
2024-09-26
Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-H
-
2023-508465-32-00
5
2024-09-03
Narcolepsy with Cataplexy (Narcolepsy Type 1)
-
2023-509573-23-00
4
2024-07-16
Chronic HBV Infection
-
2023-508663-70-00
4
2024-06-18
Bronchiectasis
-
2022-502899-23-00
5
2024-04-23
Hepatic Encephalopathy (OHE)
-
2023-503693-20-01
5
2024-04-10
Severe eosinophilic asthma
-
2023-506707-25-00
5
2024-04-09
Choroidal neovascularization secondary to pathologic myopia
-
2023-505543-39-00
5
2024-02-12
Chronic Obstructive Pulmonary Disease (COPD)
-
2022-500883-37-00
7
2023-10-02
This FTiH-PoC study aims to provide an early evaluation of the efficac
-
2022-502174-16-00
5
2023-09-13
Macular edema secondary to retinal vein occlusion
-
2022-502647-35-00
4
2023-09-01
Non-alcoholic steatohepatitis
-
2024-513802-77-00
5
2023-08-30
Active non-anterior non-infectious uveitis
-
2022-501794-39-00
5
2023-06-28
Uveitic Macular Edema
-
2022-501063-41-00
5
2023-04-20
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-513706-56-00
4
2023-03-22
Acute-on-chronic liver failure (ACLF) is characterized by hepatic and
-
2023-504238-23-00
5
2023-01-17
Hepatitis B, Chronic
-
2024-514975-16-00
4
2022-12-22
Non-infectious, Intermediate-, Posterior- or Pan-uveitis
-
2024-515185-13-00
5
2022-12-21
geographic atrophy